Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-05-30

Clinical Trial Update: The Effect of SOD Enzyme on Frailty and HRQOL Among Indonesian Pre-frail Elderly: A Double Blind Randomized Controlled Trial [Phase 4]

View source ↗

Summary

A Phase 4, double-blind randomized trial in Indonesian pre-frail elderly assesses whether a superoxide dismutase (SOD) enzyme improves frailty status and health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Superoxide Dismutase (superoxide dismutase)

Snippet

Sponsor: Indonesia University | Conditions: Pre-frail Elderly | Phase 4 | Status: UNKNOWN